Literature DB >> 7075421

Diazepam absorption: effects of age, sex, and Billroth gastrectomy.

H R Ochs, H Otten, D J Greenblatt, H J Dengler.   

Abstract

The kinetics of diazepam absorption were assessed in 37 healthy volunteers, aged 19--79 years, who ingested a single 5-mg tablet in the fasting state. Diazepam plasma concentrations were measured by gas chromatography in multiple samples drawn over the next 72 hr. After a lag time averaging 12 min elapsed between tablet ingestion and the start of absorption, first-order absorption proceeded with a mean half-life of 19 min (range: 0--96 min), with peak plasma concentrations reached 0.9 hr after dosage (range: 0.25--2.5 hr). Age and sex did not influence absorption kinetics. Peak plasma concentrations averaged 157 ng/ml, and tended to be higher in women than in men because of lower body weights in women. Peak levels also declined with age, probably due to increased volume of distribution of diazepam in the elderly. Absolute systemic availability of oral diazepam was evaluated in seven of the subjects who received intravenous diazepam on another occasion. Based on areas under the oral versus intravenous plasma concentration curve, bioavailability of diazepam averaged 97%. Six male patients, at least 2 years after undergoing Billroth gastrectomy, also participated in the diazepam absorption study. Absorption kinetic parameters were nearly identical to those in six healthy age-matched male volunteers without gastrointestinal disease. Thus absorption of oral diazepam in the fasting state is rapid and nearly complete, and is minimally influenced by age, sex, or Billroth gastrectomy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075421     DOI: 10.1007/bf01296920

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

Review 1.  PHARMACOLOGIC ASPECTS OF AGING: A SURVEY OF THE EFFECT OF INCREASING AGE ON DRUG ACTIVITY IN ADULTS.

Authors:  A D BENDER
Journal:  J Am Geriatr Soc       Date:  1964-02       Impact factor: 5.562

2.  Effect of age and Billroth gastrectomy on absorption of desmethyldiazepam from clorazepate.

Authors:  H R Ochs; D J Greenblatt; M D Allen; J S Harmatz; R I Shader; G Bodem
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

3.  Simultaneous gas-chromatographic analysis for diazepam and its major metabolite, desmethyldiazepam, with use of double internal standardization.

Authors:  D J Greenblatt
Journal:  Clin Chem       Date:  1978-10       Impact factor: 8.327

4.  Effect of a cocktail on diazepam absorption.

Authors:  D J Greenblatt; R I Sahder; D R Weinberger; M D Allen; D S MacLaughlin
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

5.  Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.

Authors:  S A Kaplan; M L Jack; K Alexander; R E Weinfeld
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

6.  [Biological availability of diagoxin in patients with or without gastric resection (Billroth II) (author's transl)].

Authors:  H Ochs; G Bodem; G Kodrat; B Savic; M P Baur
Journal:  Dtsch Med Wochenschr       Date:  1975-11-21       Impact factor: 0.628

7.  Oxazepam kinetics: effects of age and sex.

Authors:  D J Greenblatt; M Divoll; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

Review 8.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

9.  Disposition of oxazepam in relation to age, sex, and cigarette smoking.

Authors:  H R Ochs; D J Greenblatt; H Otten
Journal:  Klin Wochenschr       Date:  1981-08-17

10.  Diazepam kinetics in relation to age and sex.

Authors:  H R Ochs; D J Greenblatt; M Divoll; D R Abernethy; H Feyerabend; H J Dengler
Journal:  Pharmacology       Date:  1981       Impact factor: 2.547

View more
  14 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

2.  Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.

Authors:  Sheila Annie Peters
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 3.  Gender-specific differences in the central nervous system's response to anesthesia.

Authors:  Lana J Mawhinney; Davita Mabourakh; Michael C Lewis
Journal:  Transl Stroke Res       Date:  2012-11-29       Impact factor: 6.829

Review 4.  Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations.

Authors:  I Bernus; R G Dickinson; W D Hooper; M J Eadie
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

5.  Single and multiple dose kinetics of clobazam, and clinical effects during multiple dosage.

Authors:  H R Ochs; D J Greenblatt; M Lüttkenhorst; B Verburg-Ochs
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Diazepam, behavior, and aging: increased sensitivity or lower baseline performance?

Authors:  J V Hinrichs; M M Ghoneim
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Pharmacokinetics and dynamics of penbutolol in humans: evidence for pathway-specific stereoselective clearance.

Authors:  H R Ochs; P Hajdú; D J Greenblatt
Journal:  Klin Wochenschr       Date:  1986-07-15

Review 8.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

9.  Pharmacokinetics and absolute bioavailability of diltiazem in humans.

Authors:  H R Ochs; M Knüchel
Journal:  Klin Wochenschr       Date:  1984-04-02

Review 10.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.